Radio and PodcastLive Radio & PodcastsScience & Medicine
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology
Dr. Qun Shao discusses two multicenter studies evaluating cardiovascular adverse events associated with bispecific T‑cell engager therapies. Drawing on data from over 700 patients, the episode highlights the incidence, p...
About This Episode
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology is an episode from JACC: Clinical Electrophysiology by American College of Cardiology. Dr. Qun Shao discusses two multicenter studies evalu...
Podcast
This episode belongs to JACC: Clinical Electrophysiology.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 21, 2026, 03:23 long, audio available.
Related Episodes
Continue listening to more episodes from JACC: Clinical Electrophysiology.
Questions About This Episode
What is Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology about?
Dr. Qun Shao discusses two multicenter studies evaluating cardiovascular adverse events associated with bispecific T‑cell engager therapies. Drawing on data from over 700 patients, the episode highlights the incidence, predictors, and clinical impact of cardiovascular complications, emphasizing the importance of baseline risk assessment, targeted monitoring, and multidisciplinary management as use of these therapies continues to expand.
Where can I listen to Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology?
You can listen to Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology from?
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology is an episode from JACC: Clinical Electrophysiology by American College of Cardiology.
How long is this episode?
This episode is 03:23 long.
When was this episode published?
This episode was published on Apr 21, 2026.
Can I save Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from JACC: Clinical Electrophysiology?
Yes. This page shows related episodes from JACC: Clinical Electrophysiology when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology?
You can listen to Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Cardiovascular Adverse Events Associated with Bispecific T-cell Engager Therapy JACC: CardioOncology is from JACC: Clinical Electrophysiology by American College of Cardiology.
What are the episode details?
Published Apr 21, 2026 and 03:23 long